Home Search

viaskin - search results

If you're not happy with the results, please do another search
Viaskin Patch

Viaskin Peanut Completes Phase III Part A Study of Toddlers With No Safety Concerns

Part B expected to commence in 2018Q4 with Viaskin Peanut 250 µg.
DBV Patch Closeup

Positive Safety Results Reported for Viaskin Peanut Phase III Trial

0
The trial met its primary objective, demonstrating that Viaskin Peanut was well-tolerated with no new or unexpected adverse events.

Viaskin Peanut Phase III Trial Falls Short, Still Chance for FDA Approval

0
The Viaskin Peanut patch therapy still has 50:50 chance of approval according to research note.

Viaskin Peanut Patch: Lasting Response After Three Years

0
Pediatric patients responded with a favorable safety profile and no serious adverse effects.

Viaskin Patch Delivers Long-Lasting Peanut Desensitization After Phase IIb Trial

0
The study was designed to assess the long-term efficacy and safety of the treatment in subjects that had graduated from their earlier VIPES trial.

Viaskin Peanut, Milk and Egg Patch Therapies: Promising News from the AAAAI Conference

5
We are cautiously optimistic that a safe, effective, easy to administer treatment for food allergy may be on the horizon.

Viaskin Milk Patch Receives Positive Recommendation to Proceed to Phase II

0
The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.
Viaskin-Patch

FDA Removes Hold Allowing DBV’s Pivotal Phase 3 Peanut Patch Trial to Commence

0
The phase 3 trial of the modified Viaskin Peanut patch has been cleared for commencement.
Viaskin Patch

Skin Patch Immunotherapy Determined Safe and Effective in Toddlers With Peanut Allergy

0
According to research presented at this year's #ACAAI22 meeting.
Viaskin Peanut

Private Law Firm to Investigate Claims on Behalf of Investors in DBV Technologies

0
It is unknown how this development will affect the ability of the company to eventually offer Viaskin Peanut as an FDA approved therapy.